高级检索
当前位置: 首页 > 详情页

Peptide-driven approaches in advanced wound healing materials

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of General Surgery, Wusheng County People's Hospital (Wusheng Hospital Affiliated Hospital of North Sichuan Medical College), Guangan 638400, China. [2]Preventive Medicine, Shandong Academy of Occupational Health and Occupational Medicine, Occupational Disease Hospital of Shandong First Medical University (Shandong Province Hospital Occupational Disease Hospital), Shandong First Medical University (Shandong Academy of Medical Sciences), Jinan, Shandong, China. [3]Department of Pharmacology and NUS Centre for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore. [4]Department of Urology, Kidney and Urology Center, Pelvic Floor Disorders Center, Scientific Research Center, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen 518107, China. [5]Department of Radiation Oncology, Precision Radiation in Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, Sichuan 610041, China.
出处:
ISSN:

关键词: peptide-based materials wound healing antimicrobial peptides tissue regeneration bioactive hydrogels

摘要:
Peptide-based materials, such as antimicrobial peptides (AMPs), cell-penetrating peptides (CPPs), angiogenic peptides, and extracellular matrix (ECM)-mimetic peptides, offer unique multifunctional benefits for wound healing, including infection control, enhanced angiogenesis, immunomodulation, and tissue regeneration. Representative platforms, including hydrogels, nanofibers, functionalized dressings, and delivery systems, leverage these peptides for sustained therapeutic action and improved healing. Despite these promising advances, significant translational barriers remain, including peptide stability, enzymatic degradation, manufacturing scalability, and regulatory approval. Addressing these barriers through optimized peptide engineering and delivery strategies is essential for the clinical translation and wider clinical adoption of peptide-driven wound therapies.Copyright © 2025 Elsevier Ltd. All rights reserved.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版
大类 | 2 区 医学
小类 | 2 区 药学
最新[2025]版
大类 | 2 区 医学
小类 | 2 区 药学
JCR分区:
出版当年[2024]版:
Q1 PHARMACOLOGY & PHARMACY
最新[2024]版:
Q1 PHARMACOLOGY & PHARMACY

影响因子: 最新[2024版] 最新五年平均 出版当年[2024版] 出版当年五年平均 出版前一年[2024版]

第一作者:
第一作者机构: [1]Department of General Surgery, Wusheng County People's Hospital (Wusheng Hospital Affiliated Hospital of North Sichuan Medical College), Guangan 638400, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:65780 今日访问量:0 总访问量:5151 更新日期:2025-12-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号